Eric Schmidt is a managing director and senior research analyst. He covers over 20 large-, mid-, and small-cap biotechnology stocks. Dr. Schmidt has been recognized in polls conducted by Alpha Magazine, Institutional Investor, Reuters, and The Wall Street Journal. Prior to joining Cowen in 1998 he was a vice president covering the biotechnology sector for UBS Securities. He holds a BA in chemistry from the University of Pennsylvania and a Ph.D. in biochemistry from the Massachusetts Institute of Technology, where he serves on the Visiting Committee for the Department of Biology.
Managing Director, Health Care - Biotechnology
599 Lexington Avenue
New York, NY 10022
D 646 562 1345